We believe that science is closer than it has ever been to solving the most pressing of human disease afflictions, but one common unmet need is often overlooked: the ability to actively target diseased cells without harming healthy cells.
Cytonus© was founded with a simple goal: to focus treatment where it is needed. Our innovative approach addresses the limitations all powerful therapeutics have: toxicity and off-target effects, by which otherwise life-saving therapeutics fail in clinical trials or having suboptimal effect on disease. We have addressed these problems with a targeted, controllable, and safe drug-delivery platform that revolutionizes how we treat disease.
Our proprietary Cargocyte drug-delivery platform is a biological drone that is programmed to go to specific tissues and produce a therapeutic at the site of the disease for a specific time period.
Our technology was developed at University of California, San Diego via collaborations with leading international academic laboratories and industry partners. Scalable manufacturing, biobankability, and rapid patient-specific customization of our Cargocyte enables broader patient access to our first-in-class, best-in-class, precision medicine solution.